Amy Elizabeth Herr is the John D. and Catherine T. MacArthur Professor at the University of California, Berkeley, where she is attached to the Department of Bioengineering. At Berkeley she was also the founding executive director of the Bakar Bioenginuity Hub. Herr is a Chan Zuckerberg BioHub Investigator and the Chief Technology Officer of the Chan Zuckerberg Biohub Network, a fellow of both the National Academy of Inventors and the American Institute of Medical and Biological Engineering, as well as a co-founder of Zephyrus Biosciences, a biotechnology company that was acquired by Bio-Techne. Early life and education Amy Herr was born in Ohio, and grew up in Florida. In high school, a research project took her to the International Science and Engineering Fair, where she received an American Meteorological Society (AMS) Honorable Mention for her project focused on the performance of iced airfoils. She earned her B.S. in Engineering & Applied Science at Caltech, and her M.S. and Ph.D. in Mechanical Engineering at Stanford University where she studied under Tom Kenny and Juan Santiago as a National Science Foundation Graduate Research Fellow. Her thesis is titled "Isoelectric Focusing for Multi-Dimensional Separations in Microfluidic Devices." Career and research After completing her PhD, Herr became a staff member in the Biosystems Research Group at Sandia National Laboratories in Livermore, California from 2002 to 2007, where she worked on protein analysis in complex biological media such as saliva and serum. She joined the faculty at the University of California, Berkeley in 2007. Her laboratory focuses on developing the tools required for complex biological analysis, including identification of proteins from a single cell, in the pursuit of quantitative medicine. This proteomic information provides additional insights beyond genomic analysis. One application is analysis of proteins from circulating tumor cells, which could allow a doctor to understand how a cancer patient is responding to treatment with only a blood draw. The lab is also affiliated with University of California, San Francisco, QB3: The California Institute of Quantitative Biosciences, and the Lawrence Berkeley National Laboratory. She describes her research interests in this way:"Difficult measurement challenges exist at the interface of biology and quantitative science. Advanced measurement tools are already adding to our knowledge and capabilities in the areas of genomics and transcriptomics. As we push forward the frontier of quantitative, precise, and dynamic measurements, we’ll see even more knowledge unlocked from nature and translated into improving the